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Abstract
Background and purpose—CNS complications are often seen after heart surgery, and post-
surgical disruption of the blood-brain barrier (BBB) may play an etiologic role. The objective of
this study was to determine the prevalence of MRI-detected BBB disruption (Hyperintense Acute
Reperfusion Marker: HARM) and DWI lesions after cardiac surgery.
Materials & methods—All patients had an MRI after cardiac surgery. In half the patients
(group 1), we administered gadolinium 24 hours after surgery and obtained high-resolution DWI
and FLAIR images 24-48 hours later. In the other half (group 2), we administered gadolinium at
the time of the post-operative scan (2-4 days after surgery). Two stroke neurologists evaluated the
images.
Results—We studied 19 patients. None of the patients had clinical evidence of a stroke or
delirium at the time of the gadolinium administration or the scan, but 9 patients (47%) had HARM
(67% in group 1 and 30% in group 2, p=0.18) and 14 patients (74%) had DWI lesions (70% in
group 1 and 78% in group 2, p=1.0). Not all patients with DWI lesions had HARM, and not all
patients with HARM had DWI lesions (p=0.56).
Conclusions—Almost half the patients undergoing cardiac surgery have evidence of HARM
and three quarters have acute lesions on DWI after surgery. BBB disruption is more prevalent in
the first 24 hours after surgery. These findings suggest that MRI can be used as an imaging
biomarker to assess therapies that may protect the BBB in patients undergoing heart surgery.
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INTRODUCTION
Between 1% and 6% of patients have clinical evidence of stroke after heart surgery, and the
incidence of hyperintense lesions on DWI is even higher (18%-60%). These DWI lesions
typically are small, often do not lead to clinical deficits, and their long-term clinical
implications are not well understood.1-7 Because it leads to brain changes, cardiac surgery
has been proposed as a model to screen potential neuroprotective agents, particularly when
DWI is used to identify incident lesions.2, 8
In addition to ischemia due to hypoperfusion and distal embolization, cardiac surgery elicits
a systemic inflammatory response that may lead to a disruption of the blood-brain barrier
(BBB) and neurological dysfunction.9 In experimental models the use of cardiopulmonary
bypass leads to opening of the BBB.10, 11 Disruption of the BBB can be seen on MRI as
enhancement of the subarachnoid space on post-contrast FLAIR images. Under normal
conditions gadolinium-containing compounds do not cross the BBB. Under ischemic
conditions, however, an increase in matrix-metalloproteinase-9 (MMP-9) leads to
proteolytic breakdown of the BBB integrity that allows passage of gadolinium to the CSF
and the parenchyma. Because gadolinium shortens T1, it disrupts the CSF signal
suppression of FLAIR, and CSF appears hyperintense. The sensitivity of FLAIR for low-
contrast concentrations is >10-fold higher than for T1 imaging, and much lower
concentrations of gadolinium are required to see the gadolinium hyperintensity on FLAIR
than on T1-weighted images..12-16
The enhancement of the CSF on FLAIR, an imaging biomarker called hyperintense acute
reperfusion marker (HARM), is seen in 30-40% of patients with acute stroke and around
20% of patients with TIA without DWI lesions on acute MRI, and is more common in
patients treated with pharmacologic or mechanical reperfusion therapies.17, 18 It has been
observed in animal models of ischemia, in patients with acute stroke, and in patients
undergoing reperfusion procedures, including carotid artery angioplasty and
stenting.12, 13, 17, 19-22 It is associated with age, reperfusion, thrombolysis, endovascular
procedures, changes in matrix metalloproteinases, hemorrhagic transformation and poor
outcome.17, 20, 21, 23-26 Recent studies confirm that HARM is due to enhancement of the
CSF and not of the parenchyma and that gadolinium in the CSF is the cause of the
enhancement.15, 20 HARM is a biomarker with potential use in proof- of-concept clinical
trials of agents that prevent BBB breakdown and consequent brain damage.27-29
The purpose of this study was to determine whether BBB disruption occurs after on- and
off-pump coronary artery bypass grafting (CABG) or valve repair surgery and, if so, its
relationship to incident ischemic lesions.
METHODS
Subjects
We enrolled patients who had on- or off-pump CABG or aortic or mitral valve replacement
if they were 18 years of age or older and functionally independent (mRS<2). We excluded
patients who had dementia, cognitive dysfunction, or a psychiatric disorder; were scheduled
for concomitant carotid endarterectomy or pacemaker placement; had a contraindication to
MRI; or were pregnant. The Institutional Review Board of the National Institute of
Neurological Disorders and Stroke and Suburban Hospital in Bethesda, MD and Washington
Hospital Center in Washington, D.C. approved the study and all patients gave informed
consent to participate.
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Study procedures
Initially we enrolled patients in this study before surgery (patients in group 1). After several
months it became clear that it was not practical to enroll and consent patients before surgery:
because the time between the decision to operate and the surgery was short, patients were
reluctant to enroll in a study that required them to have a pre-operative MRI. We then started
enrolling patients after surgery, once they were hemodynamically stable (group 2). Enrolling
and imaging patients at different times allowed us to assess the permeability of the BBB at
different time-points. We administered gadolinium (0.1 mmol/kg) to patients in group 1
approximately 24 hours after surgery; these patients had a post-operative MRI once they
were hemodynamically stable (typically around 48 hours after surgery). The half-life of
gadolinium in blood is 1.7 hours yet it remains in the subarachnoid space for several days;
any HARM on the post-operative MRI scan therefore reflects the status of the BBB around
the time of the injection. Group 1 patients also had a pre-operative MRI. Patients in group 2
received gadolinium at the time of the post-operative MRI and did not have a pre-operative
scan. Throughout the study, a neurologist examined the patients and administered the Mini
Mental State Examination (MMSE) and the Delirium Rating Scale (DRS) before surgery
and at the time of gadolinium administration (group 1), and at the time of the post-operative
MRI scan (group 1 and 2).30
Imaging and image analysis
Imaging was done in a Philips 3T or a General Electric 1.5T scanner; prior studies have
shown that the field strength of the MRI does not affect the HARM detection rate.31 Typical
MRI parameters include 24 cm FOV, 35 contiguous interleaved slices, 3.5-4 mm thick and
co-localized across series; trace-weighted DWI images were obtained at b=1000 from a
13-15 direction DTI sequence with an in-plane resolution of 2.5×2.5mm and TR/TE=10s/
58ms at 3T or TR/TE=10s/72ms at 1.5T. T2-FLAIR images were obtained with an in-plane
resolution of 0.94×0.94 mm, TR/TE=9000/120 ms and TI=2600 ms at 3T or TR/
TE=9000/140 ms and TI=2200 ms at 1.5T.
Two stroke neurologists blinded to the clinical and surgical variables read the MRIs, and a
third reader settled disagreements. The readers counted the number of lesions on the post-
operative DWI and classified them based on location (cortical, subcortical or mixed) and
appearance (punctate or confluent). They also reviewed the pre- and post-contrast FLAIR
images looking for the presence of HARM and classified it by location (sulcal, ventricular
and/or generalized) and severity (mild, moderate or severe) (Figure 1).
Statistical Analysis
The primary outcome measures were evidence of post-operative ischemic lesions on DWI
and presence of HARM on FLAIR. We analyzed the outcomes as dichotomous variables.
We did the statistical analyses with SPSS for Mac and compared categorical variables using
chi-square or Fisher’s exact test and means with the independent sample t-test. All p-values
are two-tailed.
RESULTS
We report the imaging findings in 19 patients with mean age of 67.4 years (SD ±10.2). Six
patients had off-pump CABG and 13 had surgery with the use of a cardiopulmonary bypass
pump (7 CABG and 6 valvular surgery). The mean pump time was 130 minutes (SD ±23,
range 82-179 minutes) and the mean cross-clamp time was 101 minutes (SD ±27, range
56-160 minutes). The mean pump time was similar between the 7 patients who had CABG
and the 6 who had valve repair (141 [± 22] vs. 120 [±22] minutes, respectively; p=0.13).
Similarly, cross-clamp time did not differ between the CABG and the valve repair patients
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(109 [±26] vs. 92 [±26] minutes, respectively; p=0.26). Seven patients were examined with
a 3T scanner and 12 with 1.5T.
The mean time from surgery to gadolinium administration in patients in group 1 was 21.6
hours [±1.2]; the corresponding value for patients in group 2 was 88.1 hours [±21.2]
(p<0.001). The integrity of the BBB was therefore assessed, on average, 21.6 hours after
surgery in the first group of patients and 88.1 hours after surgery in the second group. The
time from surgery to the post-operative MRI was also shorter in group 1 than in group 2 (52
hours [±15.4] vs. 88.1 hours [±21.2]; p<0.001). The nine patients in group 1 had a pre-
operative scan: only one of them (11%) had DWI lesions before surgery. None of the
patients had clinical evidence of a stroke after surgery and all had consistently normal
neurological examinations and scores in the MMSE and DRS,
We found HARM in 9 patients (47%); of these, seven (78%) also had DWI lesions (table 1).
Most patients had mild/moderate HARM and only two had severe sulcal or background
HARM; both patients were in group 1 (Figure 2 and 3). There were more than twice as
many patients with HARM in group 1 than in group 2 (66.7% vs. 30%; p=0.18). The
proportion of patients with HARM was similar in patients who had on-vs. off-pump
procedures (38% vs. 50%, p=1.0).
DWI lesions were seen in 14 (74%) of the 19 patients who had a post-operative scan. In
these patients, the mean number of lesions was 5.6 (SD ±4.7) and the median was 4 (range
1-18). The proportion of patients with DWI lesions was similar in group 1 and group 2 (78%
vs. 70%; p=1.0). The incidence of lesions (as a dichotomous variable) did not differ by type
of surgery (valvular, CABG and off-pump CABG, p=0.54). The proportion of patients who
had DWI lesions was similar (83% vs. 69%, p=0.63) in those who had off-pump versus on-
pump procedures. Not all patients with DWI lesions had HARM, and not all patients with
HARM had DWI lesions, and the association between DWI lesions and HARM was not
significant (p=0.56; table 1). Among the 7 patients who had DWI lesions and HARM, 3 had
background HARM only; 1 had sulcal, background and ventricular HARM; and 3 had sulcal
HARM only. The four patients with sulcal HARM had DWI lesions in multiple vascular
territories. In 2 of these patients, the HARM was not in the vascular territory of the DWI
lesions. In the other 2 patients, there was HARM in at least one of the affected vascular
territories, but not all sulcal HARM was contiguous with the DWI lesion (online table).
DISCUSSION
MRI-demonstrated BBB disruption after cardiac surgery occurred in almost half the patients
in our sample. The incidence of HARM was higher among patients who received
gadolinium within 24 hours of surgery. Because of the short plasma distribution and
elimination half-life of gadolinium (0.2 ± 0.13 hours and 1.6 ± 0.13 hours, respectively), our
findings suggest that the BBB may open during or soon after heart surgery and close shortly
thereafter. Animal studies show that the BBB opens soon after ischemia. In an MCA
occlusion (MCAO) rat model, brain sucrose uptake, a marker of BBB disruption, increased
3 hours after reperfusion, was maximal at 48 hours, and persisted for up to 14 days.32 In
another study, gadolinium enhancement of the ventricles ipsilateral to stroke was seen on
FLAIR within 1 hour of reperfusion in rats subject to MCAO, suggesting that the blood-CSF
barrier can be disrupted within minutes of onset of ischemia, and this enhancement increases
by 24 hours. At 48 hours parenchymal enhancement on T1 was evident, suggesting a more
widespread BBB opening.23 In humans with stroke HARM can be seen within the first 6
hours of symptom onset, and persists for up to 5 days.17
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The clinical relevance of HARM in cardiac surgery patients is unclear, as our patients did
not have evidence of neurologic or cognitive dysfunction at the time of gadolinium
administration -when the integrity of the BBB was evaluated- or at the time of the MRI scan.
Further studies are needed to determine if BBB disruption after heart surgery is clinically
relevant and if it occurs because of focal or global ischemia, reperfusion injury, changes in
the level of matrix metalloproteinases, or inflammatory mechanisms. Our findings suggest
that such studies should focus on the first 24 hours after surgery.
The incidence of DWI lesions in our series is higher than previously reported.1-7 Several
features of our MRI sequences may explain this higher incidence: we used thin slices to
decrease partial volume averaging with normal tissue on CSF; used short echo time to
decrease T2 loss; used a DTI sequence with 13-15 directions instead of a conventional DWI
sequence to increase averaging and signal-to-noise; and, on the 1.5 T scanner, used a twice
refocused spin echo to decreased eddy currents.
In our patients, most DWI lesions were cortical. The clinical relevance of such small DWI
lesions seen after invasive procedures, however, remains unknown.33 Case studies have
shown that over time some of these lesions may become invisible on 3D T1-weighted and
FLAIR images, but still lead to a loss of gray matter.34 These small cortical lesions may be
another pathway to cortical atrophy and may explain why some patients undergoing cardiac
surgery develop cognitive impairment.
In our study, we did not find an association between HARM and DWI lesions. Cerebral
ischemia and reperfusion are associated with opening of the blood brain barrier, which has
been described in patients with transient symptoms without DWI lesions.18 A proposed
mechanism for BBB disruption after ischemia of any duration is activation of inflammatory
cascades and proteolytic enzymes.25, 35 The effect of ischemia on BBB disruption may be
diffuse.26 HARM is not always related to the site of ischemia.17, 21 In addition, in patients
undergoing cardiac surgery, the procedure activates a systemic inflammatory response and
the production of immune mediators that may contribute the development of acute and
chronic neurological dysfunction and disruption of the blood brain barrier, a process also
seen in patients with traumatic brain injury and hemorrhagic and ischemic stroke. 36, 37
Future studies are needed to clarify the role of different immune mediators in the genesis of
HARM in these patients.
The use of cardiopulmonary bypass (CPB) may lead to disruption of the BBB, perhaps on
the basis of a systemic inflammatory response.9, 11 Case series suggest that neurologic
complications are less when the CABG is done off-pump, but clinical trials have not
confirmed this observation. 38, 39 In our series, the proportion of patients with DWI lesions
and HARM was similar in patients who had an off-pump CABG as those who had an on-
pump procedure (CABG or valve replacement). The reasons why patients who have an off-
pump procedure have disruption of the BBB are not clear and merit further study looking at
serum biomarkers of inflammation and levels of different matrix metalloproteinases.
Our study has some limitations, hence our findings are preliminary and require replication in
a larger prospective study. Our sample was small, and the lack of association between
HARM and DWI lesions may be a type II error rather than a definitive finding. It is possible
that some of the DWI lesions were present before surgery, but only one of the nine
participants who had a pre-surgical MRI had DWI lesions at baseline. Breathing high
oxygen concentration may lead to CSF hyperintensity on FLAIR due to the T1 shortening
effect of oxygen, a phenomenon described only in intubated patients and volunteers
breathing 100% O2, and in that case the CSF enhancement is global and severe. 40, 41 We do
not have information about the use of supplemental oxygen in our patients, but we know that
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none was intubated or using a non-rebreather mask, so we assume that any HARM was not
due to high CSF oxygen concentration. Patients were subject to a variety of surgical
procedures, but because of the sample size we cannot determine whether features inherent to
each surgery played an etiologic role in the development of brain changes. Finally, we do
not have longitudinal follow-up data to determine the clinical implications of BBB
disruption shortly after cardiac surgery.
In conclusion, almost half the patients undergoing cardiac surgery have evidence of HARM
and three quarters have acute lesions on DWI after surgery, and BBB disruption is more
prevalent in the first 24 hours after surgery. These findings suggest that MRI can be used as
an imaging biomarker to assess therapies that may protect the BBB in patients undergoing
heart surgery.
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Figure 1.
Classification of HARM by location and severity. Definitions used for HARM classification.
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Figure 2.
Generalized HARM 74-year old man who underwent off-pump CABG. A. Baseline FLAIR
obtained before surgery. B. Post-gadolinium scan. Gadolinium was administered 20 hours
after surgery, and a 3T MRI was done 20 hours later. Post-gadolinium FLAIR shows
enhancement throughout the subarachnoid space (severe sulcal and background HARM).
The CSF in the ventricles appears gray (mild/moderate ventricular HARM). Gadolinium
enhancement is also seen in the eye. C. DWI obtained after surgery. Patient had 4 DWI
lesions.
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Figure 3.
Sulcal HARM 86-year old man who underwent CABG. A: Baseline FLAIR done before
surgery. B. Post-gadolinium FLAIR. Gadolinium was administered 23 hours after surgery
and the 1.5T MRI was obtained 27 hours later. Post-gadolinium FLAIR shows bright
enhancement in the right frontal and left parietal subarachnoid space (severe sulcal HARM,
arrows). C. Postoperative DWI. The patient had six DWI lesions. .
Merino et al. Page 12
AJNR Am J Neuroradiol. Author manuscript; available in PMC 2013 March 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Merino et al. Page 13
Table 1
Association of HARM and DWI lesions
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